PUBLICACIONES

2021

  • Moreno Calvete MC, Ballesteros Rodriguez FJ. Non-pharmacological strategies for self-directed and interpersonal violence in people with severe mental illness: a rapid overview of systematic reviews. Bmj Open. 2021; 11(1): 43576-43576. DOI:10.1136/bmjopen-2020-043576.
  • Escudero J, Munoz JL, Morera Herreras T, Hernandez R, Medrano J, Domingo Echaburu S et al. Antipsychotics as environmental pollutants: An underrated threat?. Sci Total Environ. 2021; 769: 144634-144634. DOI:10.1016/j.scitotenv.2020.144634.
  • Gonzalez Fraile E, Ballesteros J, Rueda J, Santos Zorrozua B, Sola I, McCleery J. Remotely delivered information, training and support for informal caregivers of people with dementia. Cochrane Database Syst Rev. 2021; 1(1): 6440-6440. DOI:10.1002/14651858.CD006440.pub3.
  • Arnaiz A, Zumarraga M, Erkoreka L, Olivas O, Arrue A, Zamalloa MI et al. Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter. Schizophr Res. 2021; 228: 382-384. DOI:10.1016/j.schres.2021.01.012.
  • Lertxundi U, Domingo Echaburu S, Hernandez R, Medrano J, Orive G. Venlafaxine and desvenlafaxine to be included in the surface water Watch List. Aust N Z J Psychiatry. 2021; 55(11): 1112-1112. DOI:10.1177/0004867421998787.
  • Recio Barbero M, Segarra R, Zabala A, Gonzalez Fraile E, Gonzalez Pinto A, Ballesteros J. Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms. Front Psychiatry. 2021; 12: 631589-631589. DOI:10.3389/fpsyt.2021.631589.
  • Basterreche N, Arrue A, Arnaiz A, Olivas O, Zumarraga M. Lithium: An old treatment for a new indication. Actas Esp Psiquiatr. 2021; 49(3): 122-127
  • Penas P, Uriarte J, Gorbena S, Slade M, Moreno Calvete M, Iraurgi I. Discrepancy between experience and importance of recovery components in the symptomatic and recovery perceptions of peoplewith severe mental disorders. BMC Psychiatry. 2021; 21(1): 277-277. DOI:10.1186/s12888-021-03287-y.
  • Garcia Ribas G, Garcia Arcelay E, Montoya A, Maurino J, Ballesteros J. Quantifying Knowledge of Alzheimer’s Disease: An Analysis of the Psychometric Properties of the Alzheimer’s Disease Knowledge Scale. Neurol Ther. 2021; 10(1): 213-224. DOI:10.1007/s40120-021-00230-x.
  • Erkoreka L, Zamalloa I, Rodriguez S, Munoz P, Mendizabal I, Zamalloa MI et al. Attachment anxiety as mediator of the relationship between childhood trauma and personality dysfunction in borderline personality disorder. Clin Psychol Psychother. 2021; 29(2): 501-511. DOI:10.1002/cpp.2640.
  • Basterreche N, Arrue A, Arnaiz A, Olivas O, Zumarraga M. CLINICAL NOTE: Lithium: An old treatment for a new indication. Actas Esp Psiquiatr. 2021; 49(3): 125-127
  • Saposnik G, Bueno Gil G, Sempere AP, Rodriguez Antiguedad A, del Rio B, Baz M et al. Regret and Therapeutic Decisions in Multiple Sclerosis Care: Literature Review and Research Protocol. Front Neurol. 2021; 12. DOI:10.3389/fneur.2021.675520.
  • Meca Lallana JE, Maurino J, Perez Miralles F, Forero L, Sepulveda M, Calles C et al. Quantifying the patients perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire. PLoS One. 2021; 16(7): 255317-255317. DOI:10.1371/journal.pone.0255317.
  • Erkoreka L, Zumarraga M, Arrue A, Zamalloa MI, Arnaiz A, Olivas O et al. Genetics of adult attachment: An updated review of the literature. World J Psychiatry. 2021; 11(9): 530-542. DOI:10.5498/wjp.v11.i9.530.
  • Pascual FS, Munoz A, Oraa R, Florez G, Notario P, Seijo P et al. Perception of a New Prolonged-Release Buprenorphine Formulation in Patients with Opioid Use Disorder: The PREDEPO Study. Eur Addict Res. 2021; 28(2): 1-12. DOI:10.1159/000520091.
  • Argaluza J, Domingo Echaburu S, Orive G, Medrano J, Hernandez R, Lertxundi U. Environmental pollution with psychiatric drugs. World J Psychiatry. 2021; 11(10): 791-804. DOI:10.5498/wjp.v11.i10.791.
  • Muela A, Balluerka N, Sansinenea E, Machimbarrena JM, Garcia Ormaza J, Ibarretxe N et al. A Social-Emotional Learning Program for Suicide Prevention through Animal-Assisted Intervention. Animals. 2021; 11(12). DOI:10.3390/ani11123375.
  • Erkoreka L, Basterreche N, Olivas O, Arnaiz A, Zamalloa MI, Moreno Calle T et al. Plasma gamma-aminobutiric acid levels in schizophrenia patients: correlation with positive, negative and global impression symptom severity. Eur Neuropsychopharmacol. 2021; 53: 112-113. DOI:10.1016/j.euroneuro.2021.10.151.
  • Gallego OO, Basterreche N, Arnaiz A, Erkoreka L, Zamalloa MI, Moreno MT et al. Polymorphisms in dopamine d2 receptor gene are associated with obesity in antipsychotic treatment patients: no relationship with eating habits changes. Eur Neuropsychopharmacol. 2021; 53: 219-219. DOI:10.1016/j.euroneuro.2021.10.285.
  • Unzueta Larrinaga P, Ibarra Lecue I, Barrena Barbadillo R, Diez Alarcia R, Landabaso MA, Mendibil B et al. Cannabis abuse differently regulates 5-HT2A receptors and Akt protein in platelets of subjects with schizophrenia. Eur Neuropsychopharmacol. 2021; 53: 666-667. DOI:10.1016/j.euroneuro.2021.10.763.
  • Arellano JJR, Zallo F, Gardenal E, Rodriguez Carrillo M, Ramirez Penas O, Arrue A et al. Generalized and concomitant astrocytic atrophy in sporadic and familiar Alzheimer’s disease. Eur Neuropsychopharmacol. 2021; 53: 539-540. DOI:10.1016/j.euroneuro.2021.10.806.

2020

  • Varela Barca L, Fernández Felix BM, Navas Elorza E, Mestres CA, Muñoz P, Cuerpo Caballero G, et al. Prognostic assessment of valvular surgery in active infective endocarditis: multicentric nationwide validation of a new score developed from a meta-analysis. Eur J Cardio-Thorac Surg. 2020; 57(4): 724-731. DOI:10.1093/ejcts/ezz328.
  • Inchausti L, Gorostiza I, Gonzalez Torres MA, Oraa R. Diagnostic stability in substance-induced psychosis. Rev Psiquiatr Salud Ment. 2020. DOI:10.1016/j.rpsm.2019.10.005.
  • Erkoreka L, Zamalloa I, Rodriguez S, Muñoz P, Catalan A, Arrue A, et al. Genetic modulation of facial emotion recognition in borderline personality disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2020; 99: 109816-109816. DOI:10.1016/j.pnpbp.2019.109816.
  • Lertxundi U, Hernández R, Medrano J, Orive G. Drug pollution and pharmacotherapy in psychiatry: A «platypus» in the room. Eur Psychiat. 2020; 63(1). DOI:10.1192/j.eurpsy.2020.32.
  • Uriarte JJ, Penas P, Moreno Calvete MC, Ridgway P, Iraurgi I. Evidence of psychometric adequacy of the Spanish Adaptation of REE: Recovery Enhancing Environment. Actas Esp Psiquiatr. 2020; 48(2): 75-88
  • Meca Lallana J, Maurino J, Angel Hernandez Perez M, Sempere AP, Brieva L, Garcia Arcelay E, et al. Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective. Neurol Ther. 2020; 9(1): 173-179. DOI:10.1007/s40120-020-00176-6.
  • Erkoreka L, Ozamiz Etxebarria N, Ruiz O, Ballesteros J. Assessment of Psychiatric Symptomatology in Bilingual Psychotic Patients: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2020; 17(11). DOI:10.3390/ijerph17114137.
  • Rodriguez Sanchez JM, Setien Suero E, Suarez Pinilla P, Mayoral Van Son J, Vazquez Bourgon J, Gil Lopez P, et al. Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort. Psychol Med. 2020; 52(4): 1-10. DOI:10.1017/S0033291720002408.
  • Penas P, Uriarte JJ, Gorbena S, Moreno Calvete MC, Ridgway P, Iraurgi I. Psychometric Adequacy of Recovery Enhancing Environment (REE) Measure: CHIME Framework as a Theory Base for a Recovery Measure. Front Psychiatry. 2020; 11: 595-595. DOI:10.3389/fpsyt.2020.00595.
  • Morentin B, Suarez Mier MP, Monzo A, Ballesteros J, Molina P, Lucena J. Sports-related sudden cardiac death in Spain. A multicenter, population-based, forensic study of 288 cases. Rev Esp Cardiol (Engl Ed). 2020; 74(3): 225-232. DOI:10.1016/j.rec.2020.05.044.
  • Moreno Calvete MC, Ruiz Ibanez I, Uriarte JJ. Scoping review protocol on non-pharmacological interventions for interpersonal and self-directed violence in adults with severe mental illness. Bmj Open. 2020; 10(9): 37006-37006. DOI:10.1136/bmjopen-2020-037006.
  • Meca Lallana J, Hernandez Perez MA, Sempere AP, Ruiz LB, Garcia Arcelay E, Terzaghi M, et al. The patients’ perspective in multiple sclerosis: the SymptoMScreen questionnaire correlates with clinical characteristics and clinician-assessed outcomes. Neurology. 2020; 94(15)
  • Basterreche N, Arrue A, Arnaiz A, Olivas O, Zumarraga M. Repeat episode of late-onset psychosis associated with efavirenz. Actas Esp Psiquiatr. 2020; 48(4)
  • Perez M, Amayra I, Lazaro E, Garcia M, Martinez O, Caballero P, et al. Intrusion errors during verbal fluency task in amyotrophic lateral sclerosis. PLoS One. 2020; 15(5). DOI:10.1371/journal.pone.0233349.
  • Arietaleanizbeaskoa MS, Sancho A, Olazabal I, Moreno C, Gil E, Garcia Alvarez A, et al. Effectiveness of physical exercise for people with chronic diseases: the EFIKRONIK study protocol for a hybrid, clinical and implementation randomized trial. BMC Fam Pract. 2020; 21(1): 227-227. DOI:10.1186/s12875-020-01298-4.
  • Viada C, Bouza C, Fors M, Frias A, Alvarez M, Garcia L, et al. Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer. Qual Life Res. 2020; 29(12): 3441-3448. DOI:10.1007/s11136-020-02584-5.
  • Guillen V, Rueda JR, Lopez Argumedo M, Sola I, Ballesteros J. Apomorphine for the Treatment of Erectile Dysfunction: Systematic Review and Meta-Analysis. Arch Sex Behav. 2020; 49(8): 2963-2979. DOI:10.1007/s10508-020-01817-5.
  • Catalan A, Garcia L, Sanchez Alonso S, Gil P, Diaz Marsa M, Olivares JM, et al. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis. Early Interv Psychiatry. 2020; 15(6): 1584-1594. DOI:10.1111/eip.13098.
  • Erkoreka L, Zamalloa I, Munoz P, Rodriguez S, Arrue A, Zamalloa MI, et al. Genetic modulation and gene-environment interaction of attachment in cluster b personality disorders. Eur Psychiat. 2020; 63: 152-152
  • Erkoreka L, Zamalloa I, Munoz P, Rodriguez S, Arrue A, Zamalloa MI, et al. Impact of parental psychopathology in the attachment style of cluster b personality disorders. Eur Psychiat. 2020; 63: 202-203
  • Moreno Calvete MC. The risk factors of self-directed violence in severe mental illness. A scoping review. Eur Psychiat. 2020; 63: 569-569

2019

  • Lertxundi U., Erezuma I., Hernandez R., Medrano J., Garcia M., Aguirre C.. Antipsychotics and pituitary tumors: An analysis of the European pharmacovigilance database (EudraVigilance). Int Clin Psychopharmacol. 2019; 34(2): 89 – 92. FI: 1,638(Q3). DOI: 10.1097/YIC.0000000000000247.
  • Penas, Patricia, Iraurgi, Ioseba, Concepción Moreno, M., Uriarte, Jose J.. How is evaluated mental health recovery?: A systematic review. Actas Esp. Psiquiatri.. 2019; 47(1): 23 – 32. FI: 1,479(Q3).
  • Munoz Garcia, Gisela, Sanchez Martinez de Luna, Maria del Mar, Eskubi Goienetxe, Izaskun, Arrieta Echeita, Goizalde, Perez Fernandez, Jose Luis, Landaluce Lauzurica, Jose Ignacio, Lopez Aguayo, Mercedes, Bilbao Bilbao, Itziar, Ayuso Gallardo, Almudena, Vázquez Ingelmo, Montserrat, Herran, Sara, Muñoz Cano, Ramón, Gallo Fernandez, Iñaki. Design and implementation of an inter-institutional pilot project for the socio-sanitary-educational integration of children with complex chronic diseases and other special needs (EVAI: Integrated care assessment team). Int. J. Integr. Care. 2019; 19(1). FI: 2,489(Q2). DOI: 10.5334/ijic.s3451.
  • Gonzalez Serrano, Fernando, Basabe Homobono, Amaya Estibaliz, Panera Uribe, Consuelo, Garran Sabando, Encarnacion, Etxebarria Izaguirre, Izaskun, Garcia Ruiz, Myrian, Lopez Rodriguez, Carmen. Detection and psychotherapeutic treatment of perinatal depression. Int. J. Integr. Care. 2019; 19(1). FI: 2,489(Q2). DOI: 10.5334/ijic.s3112.
  • Uriarte Uriarte, Jose Juan, Penas Moran, Patricia, Moreno Calvete, Concepcion. Evaluation of the recovery model in the Bizkaia Mental Health Network. Int. J. Integr. Care. 2019; 19(1). FI: 2,489(Q2). DOI: 10.5334/ijic.s3395.
  • García-Alonso, Carlos R., Almeda, Nerea, Salinas-Pérez, Jose A., Gutierrez-Colosia, Mencia R., Uriarte-Uriarte, Jose J., Salvador-Carulla, Luis. A decision support system for assessing management interventions in a mental health ecosystem: The case of Bizkaia (Basque Country, Spain). PLoS One. 2019; 14(2): e0212179. FI: 2,776(Q2). DOI: 10.1371/journal.pone.0212179.
  • Arrue, Aurora, Angel González-Torres, Miguel, Basterreche, Nieves, Arnaiz, Ainara, Olivas, Olga, Isabel Zamalloa, M., Erkoreka, Leire, Catalan, Ana, Zumarraga, Mercedes. GAD1 gene polymorphisms are associated with bipolar I disorder and with blood homovanillic acid levels but not with plasma GABA levels. NEUROCHEM INT. 2019; 124: 152 – 161. FI: 3,994(Q2). DOI: 10.1016/j.neuint.2019.01.004.
  • Moreno-Calvete, M. C., González-Fraile, E., Uriarte-Uriarte, J. J., Ruiz-Ibanez, I., Santos, B., Ballesteros, J.. Which are the risk factors of violence in mental illness? A scoping review. Eur. Psychiat.. 2019; 56: 444 – 445. FI: 3,941(Q1).
  • Ayesa-Arriola, Rosa, Tordesillas-Gutierrez, Diana, Setien-Suero, Esther, Remon-Gallo, Diego, García González, María del Carmen, Albacete, Auria, Blanco-Campal, Alberto, Manuel Rodríguez-Sánchez, José, Crespo-Facorro, Benedicto. Verbal Memory and Voxel Based Morphometry in First Episode Non-Affective Psychosis: A Process Oriented Approach. Neuropsychology. 2019; 33(4): 568 – 580. FI: 2,477(Q2). DOI: 10.1037/neu0000540.
  • Morata, L., Cobo, J., Fernández-Sampedro, M., Guisado Vasco, P., Ruano, E., Lora-Tamayo, J., Sanchez Somolinos, M., González Ruano, P., Rico Nieto, A., Arnaiz, A., Estebanez Munoz, M., Jimenez-Mejias, M. E., Lozano Serrano, A. B., Munez, E., Rodríguez-Pardo, D., Argelich, R., Arroyo, A., Barbero, J. M., Cuadra, F., Del Arco, A., del Toro, M. D., Guio, L., Jimenez-Beatty, D., Lois, N., Martín, O., Martínez Álvarez, R. M., Martínez-Marcos, F. J., Porras, L., Ramírez, M., Vergas Garcia, J., Soriano, A.. Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections. Antimicrob. Agents Chemother.. 2019; 63(5): e02280-18. FI: 4,715(Q1). DOI: 10.1128/AAC.02280-18.
  • Javier Sanz-Fuentenebro, Francisco, Uriarte Uriarte, Jose Juan, Bonet Dalmau, Pere, Molina Rodríguez, Vicente, Bernardo Arroyo, Miquel. Pattern of use of clozapine in Spain. Variability and under -prescription. Rev Psiquiatr Salud Ment. 2019; 12(3): 151 – 162. FI: 2,927(Q2). DOI: 10.1016/j.rpsm.2018.02.005.
  • Olazagoitia-Garmendia, A., Rodriguez, J., Bilbao, J., Castellanos-Rubio, A.. An inflammation-related SNP in XPO1 5 ` UTR regulates protein amount by altering m6A mRNA methylation. Eur. J. Hum. Genet.. 2019; 27(1): 627 – 627. FI: 3,650(Q2). DOI: .
  • Lertxundi, Unax, Hernandez, Rafael, Medrano, Juan. The impact of the ambiguous definition of “month” on pharmacotherapy. Med. Hypotheses. 2019; 129: 109258 – 109258. FI: 1,322(Q4). DOI: 10.1016/j.mehy.2019.109258.
  • Domingo-Echaburu, S, Lertxundi-Etxebarria, U, Hernandez-Palacios, R, Medrano-Albeniz, J. Comments on the Anticholinergic Burden Calculator Web Tool. Farm. Hosp.. 2019; 43(5): 168 – 169. FI: (Q). DOI: 10.7399/fh.11298.
  • Arnaiz Muñoz, A., Olivas, O., Erkoreka, L., Gaton, M. A., Barreiro, A., Rodríguez, J., Arrue, A., Basterreche, N., Zumarraga, M.. Factors affecting the efficacy of adjunctive aripiprazole in risperidone- or paliperidone-induced hyperprolactinemia. Eur. Neuropsychopharmacol.. 2019; 29(6): 125 – 126. FI: 4,468(Q1). DOI: 10.1016/j.euroneuro.2019.09.208.
  • Recio-Barbero, M., Zabala, A., Segarra, R., Santos, B., Ballesteros, F. J.. Cognitive enhancers in schizophrenia: A meta-analysis of Alpha-7 nicotinic acetylcholine receptor agonists for cognitive deficits and negative symptoms. Eur. Neuropsychopharmacol.. 2019; 29(6): 465 – 466. FI: 4,468(Q1). DOI: 10.1016/j.euroneuro.2019.09.657.
  • Gallego, OO, Arrue, A, Arnaiz, A, Basterreche, N, Erkoreka, L, Varela, N, Devesa, MC, Zamalloa, MI, Zumarraga, M. Genetic variants associated with low dopaminergic activity relate to parameters included in the metabolic syndrome after treatment with antipsychotics. Eur. Neuropsychopharmacol.. 2019; 29: 154 – 155. FI: 4,468(Q1). DOI: 10.1016/j.euroneuro.2019.09.244.

2018

  • Lertxundi U, Hernandez R, Medrano J, Domingo-Echaburu S, Garcia M, Aguirre C. Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation? Int. Clin. Psychopharmacol. 2018; 33(1): 56 – 58. FI: 2,284(Q3). DOI: 10.1097/YIC.0000000000000194.
  • Santos B, Gonzalez-Fraile E, Zabala A, Guillen V, Rueda JR, Ballesteros J. Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia. J. Psychopharmacol. 2018; 32(11): 1155 – 1166. FI: 4,738 (Q1). DOI: 10.1177/0269881118805496. REVIEW.
  • Lertxundi U, Hernandez R, Corcóstegui B, Ibarra O, Mentxaka G, Medrano J. Influence of an inconsistent appearance of antipsychotics on drug adherence in patients with schizophrenia. Medicine (Baltimore). 2018; 97(44): e12990. FI: 2,028(Q2). DOI: 10.1097/MD.0000000000012990.
  • Peña J, Ibarretxe-Bilbao N, Sánchez P, Uriarte JJ, Elizagarate E, Gutierrez M, et al. Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia. J. Psychiatr. Res. 2018; 101: 21 – 27. FI: 4,000(Q1). DOI: 10.1016/j.jpsychires.2018.03.002.
  • Lertxundi U, Hernandez R, San Miguel S, Corcostegui B, Prieto M, Gonzalez U, et al. The burden of constipation in psychiatric hospitals. Int. J. Psychiat. Clin. 2018; 22(2): 143 – 150. FI: 1,337(Q4). DOI: 10.1080/13651501.2017.1384023.
  • Erkoreka L, Zumárraga M, Macías I, Angel Gonzalez-Torres M. The COMT Val158Met polymorphism exerts a common influence on avoidant attachment and inhibited personality, with a pattern of positive heterosis. Psychiatry Res. 2018; 262: 345 – 347. FI: 2,223(Q2). DOI: 10.1016/j.psychres.2017.07.053. LETTER.
  • Chung Y, Salvador-Carulla L, Salinas-Pérez JA, Uriarte-Uriarte JJ, Iruin-Sanz A, García-Alonso CR. Use of the self-organising map network (SOMNet) as a decision support system for regional mental health planning. Health Res. Policy Syst. 2018; 16(1): 35 – 35. FI: 2,179(Q2). DOI: 10.1186/s12961-018-0308-y.
  • Sanz-Fuentenebro J, Uriarte-Uriarte F, Bonet-Dalmau P, Molina-Rodriguez V, Lubeiro Juarez A, Bernardo Arroyo M. Variability and underutilisation of Clozapine in Spain. Schizophr. Bull. 2018; 44(1): 205 – 205. MEETING ABSTRACT.
  • ​Sánchez M, Castiella A, Zapata E, Zubiaurre L, Pérez-Yeboles J, Mendibil L, Iribarren A. Vitamin D levels in inpatients. Eur. Psychiat. 2018; 48: 490 – 490. MEETING ABSTRACT.
  • Trincado, S., Gonzalez, L., Uriarte, O., Ruiz de Azua, T., Peralta, D., Montero, G., Albelda, S., Irigoyen, G., Perez, D., Garnica, E., Zumarraga, M. Autoimmune Hepatitis (Immune-Mediated Liver Injury) Induced By Rosuvastatin. Gastroenterol. Hepatol. 2018; 41(5): 311 – 313. MEETING ABSTRACT.

2017

  • Arnaiz A, Zumarraga M, Olivas O, Arrue A, Gaton M, Erkoreka L, et al. Adjunctive aripiprazole in the treatment of risperidone/paliperidone-induced hyperprolactinemia. Influence of catechol-O-methyltransferase and MAOA polymorphisms. Eur Neuropsychopharmacol. 2017;27:653-4. FI:4,239(Q1). DOI:10.1016/S0924-977X(17)31223-3. ABSTRACT
  • Basterreche N, Arrue A, Arnaiz A, Erkoreka L, Peralta D, Zumarraga M. Mania preceding pancreatic cancer. Actas Esp Psiquiatri. 2017;45:43-6. FI:1,339(Q3).
  • Bilbao A, Garcia-Perez L, Retolaza-Balsategui A, Mendezona-Pena JI, Estebanez S, de la Torre-Escalera PV, et al. Psychometric properties of the EQ-5D-5L in patients with major depression disorder. Value Health. 2017;20:758. FI:4,235(Q1). DOI:10.1016/j.jval.2017.08.2141. ABSTRACT
  • Bilbao A, Garcia-Perez M, Martin-Fernandez J, Retolaza-Balsategui A, Arrasate M, Sordo T, et al. Mapping from the Bdi-Ii to the Eq-5d-5l Questionnaire in patients with major depression disorder. Value Health. 2017;20:755-6. FI:4,235(Q1). ABSTRACT
  • Erkoreka L, Navarro B. Vulnerable narcissism is associated with severity of depressive symptoms in dysthymic patients. Psychiatry Res. 2017;257:265-9. FI:2,528(Q2). DOI:10.1016/j.psychres.2017.07.061.
  • Peñas P, Moreno MC, Uriarte JJ, Ridgway P, Iraurgi I. How is evaluated mental health recovery?. Eur Psychiatry. 2017;41:199. FI:3,123(Q2). DOI:10.1016/j.eurpsy.2017.01.2145. ABSTRACT
  • Peñas P, Uriarte JJ, Ridgway P, Moreno MC, Iraurgi I. Spanish adaptation of the recovery enhancing environments (REE) measure: Preliminary results. Eur Psychiatry. 2017;41:199. FI:3,123(Q2). DOI:10.1016/j.eurpsy.2017.01.2144. ABSTRACT

2016

  • Ayesa-Arriola R, Rodriguez-Sanchez JM, Suero ES, Reeves LE, Tabares-Seisdedos R, Crespo-Facorro B. Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients. Eur Arch Psych Clin Neurosci. 2016;266:619-28. FI:3,569(Q2). DOI:10.1007/s00406-015-0667-0.
  • Ayesa-Arriola R, Setien-Suero E, Neergaard KD, Ferro A, Fatjo-Vilas M, Rios-Lago M, et al. Evidence for Trait Related Theory of Mind Impairment in First Episode Psychosis Patients and Its Relationship with Processing Speed: A 3 Year Follow-up Study. Front Psychol. 2016;7:592. FI:2,323(Q2). DOI:10.3389/fpsyg.2016.00592.
  • Calderón C, Balagué L, Iruin Á, Retolaza A, Belaunzaran J, Basterrechea J, et al. Primary care and mental health care collaboration in patients with depression: Evaluation of a pilot experience. Aten Primaria. 2016;48:356-65. FI:1,042(Q3). DOI:10.1016/j.aprim.2015.06.013. ABSTRACT
  • Cuellar AG, Pinto AG, Balsategui AR, Bacaicoa OA, Suarez JT, Zabala AF, et al. Deploying eHealth: A new approach to face depression. Int J Integr Care. 2016;16:UNSP S10. FI:2,230(Q2). DOI:10.5334/ijic.2557. ABSTRACT
  • Mayoral-van Son J, de la Foz VO, Martinez-Garcia O, Moreno T, Parrilla-Escobar M, Valdizan EM, et al. Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals: A 3-Year Naturalistic Follow-Up Study. J Clin Psychiatry. 2016;77:492-U111. FI:5,291(Q1). DOI:10.4088/JCP.14m09540.
  • Montero-Gonzalez G, Arnaiz A, Arrue A, Olivas O, Gordo E, Marin E, et al. Influence of genetic polymorphisms on hyperprolactinemia caused by risperidone or paliperidone and on the effect of adjunctive aripiprazole. Eur Neuropsychopharmacol. 2016;26:249-50. FI:4,239(Q1). DOI:10.1016/S0924-977X(16)31121-X. ABSTRACT
  • Peña J, Ibarretxe-Bilbao N, Sánchez P, Iriarte MB, Elizagarate E, Garay MA, et al. Combining social cognitive treatment, cognitive remediation, and functional skills training in schizophrenia: a randomized controlled trial. NPJ Schizophr. 2016;2:16037. DOI:10.1038/npjschz.2016.37.
  • Zumárraga M, Arrúe A, Basterreche N, Macías I, Catalán A, Madrazo A, et al. COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients. Pharmacogenomics. 2016;17:837-51. FI:2,350(Q3). DOI:10.2217/pgs-2016-0022.

2015

  • Varela-Gomez N, Mata I, Perez-Iglesias R, Rodriguez-Sanchez JM, Ayesa R, Fatjo-Vilas M, et al. Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis. Cogn Neuropsychiatry. 2015;20:144-156. FI:1,924(Q2). DOI: 10.1080/13546805.2014.991780.
  • Lertxundi U, Isla A, Solinis MA, Domingo-Echaburu S, Hernandez R, Peral-Aguirregoitia J, et al. Anticholinergic burden in Parkinson’s disease inpatients. Eur J Clin Pharmacol. 2015;71:1271-7. FI:2,710(Q2). DOI:10.1007/s00228-015-1919-7.
  • Lertxundi U, Domingo-Echaburu S, Hernandez R, Peral-Aguirregoitia J, Medrano J. Confusion regarding anticholinergic burden measurement. J Am Geriatr Soc. 2015;63:1054. FI:3,842(Q1). DOI: 10.1111/jgs.13411.
  • Lertxundi U, Hernandez R, Medrano J, Domingo S, Ruiz B, Garcia M, et al. Possible interaction between letrozole and long-acting injectable zuclopenthixol. Nord J Psychiat. 2015;69:79-80. FI:1,273(Q3). DOI: 10.3109/08039488.2014.915341.
  • Roiz-Santiáñez R, Ortiz-García V, Ayesa-Arriola R, Tordesillas-Gutiérrez D, Jorge R, Varela-Gómez N, et al. No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic resonance imaging study of first-episode patients. Psychol Med. 2015;45:2861-71. FI:5,491(Q1). DOI:10.1017/S0033291715000811.
  • Solana B, Jorquera C, Gonzalez F, Vaccari F, Nieto A, Panera C, et al. Evaluation of an outpatient intensive care Program in Public Mental Health Services in Bizkaia (Basque Country) for children with severe developmental disorders: systematization, coordination and baseline for measuring evolution. Eur Child Adolesc Psych. 2015;24:115. FI:3,339(Q1). ABSTRACT
  • Gabilondo A, Gonzalez A, Retolaza A, Fullaondo A, Prieto L, Mora J, et al. Deploying eHealth to face depression. Int J Integr Care. 2015;15. FI:1,557(Q3). ABSTRACT

2014

  • Lubrini G, Perianez JA, Rios-Lago M, Viejo-Sobera R, Ayesa-Arriola R, Sanchez-Cubillo I, et al. Clinical Spanish Norms of the Stroop Test for Traumatic Brain Injury and Schizophrenia. Span J Psychol. 2014;17:e96. FI:0,706(Q3).
  • Ayesa-Arriola R, Rodriguez-Sanchez JM, Gomez-Ruiz E, Roiz-Santiáñez R, Reeves LL, Crespo-Facorro B. No sex differences in neuropsychological performance in first episode psychosis patients. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;48:149-54. FI:3,689(Q1).
  • Gutiérrez-Fernández A, Palomino A, González-Pinto A, Ugarte A, Hernanz M, Mendibil B, et al. Novel association of Neuregulin 1 gene with bipolar disorder but not with schizophrenia. Schizophr Res. 2014;159:552-3. FI:3,923(Q1).
  • Ayesa-Arriola R, Morinigo JDL, David AS, Perez-Iglesias R, Rodriguez-Sanchez JM, Crespo-Facorro B. Lack of insight 3 years after first-episode psychosis: An unchangeable illness trait determined from first presentation?. Schizophr Res. 2014;157;271-7. FI:3,923(Q1).
  • Calderón C, Mosquera I, Balagué L, Retolaza A, Bacigalupe A, Belaunzaran J, et al. Models for Primary Care and Mental Health Collaboration in the Care of People with Depression: Main Results and Methodological Challenges of a Systematic Overview. Rev Esp Salud Publica. 2014;88:113-33. FI:0,600(Q4).
  • Arteagoitia I, Zumarraga M, Davila R, Barbier L, Santamaria G, Santamaria J. Plasma variations in stress markers: Clinical trial of two anesthetics used in regional block in the extraction of impacted inferior third molars. Med Oral Patol Oral Cir Bucal. 2014;19:274-9. FI:1,171(Q3).

2013

  • Rodríguez-Sanchez JM, Ayesa-Arriola R, Pérez-Iglesias R, Periañez JA, Martínez-García O, Gómez-Ruiz E, et al. Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study. Schizophr Res. 2013;150:121-8. FI:4,426(Q1).
  • Ayesa-Arriola R, Rodríguez-Sanchez JM, Pérez-Iglesias R, Roiz-Santianez R, Martínez-García O, Sanchez-Moreno J, et al. Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone. Psychopharmacology. 2013;227:615-25. FI:3,988(Q1).
  • Ayesa-Arriola R, Pérez-Iglesias R, Rodríguez-Sanchez JM, Pardo-García G, Tabares-Seisdedos R, Ayuso-Mateos JL, et al. Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;43:23-8. FI:4,025(Q1).
  • Ayesa-Arriola R, Rodriguez-Sanchez JM, Perez-Iglesias R, González-Blanch C, Pardo-García G, Tabares-Seisdedos Rl, et al. The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year longitudinal study. Psychiatry Res. 2013;209:302-8. FI:2,682(Q2).
  • Davila W, Basterreche N, Arrue A, Zamalloa MI, Gordo E, Davila R, et al. The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients. PLoS One. 2013; 8:e62900. FI:3,534(Q1).
  • Lertxundi U, Domingo-Echaburu S, Ruiz-Osante B, Hernández R, Peral J, Medrano J. Comments on Duran et al.’s systematic review of anticholinergic risk scales. Eur J Clin Pharmacol. 2013;69:1729. FI:2,697(Q2).
  • Paya B, Rodríguez-Sanchez JM, Otero S, Muñoz P, Castro-Fornieles J, Parellada M, et al. Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder. Schizophr Res. 2013;146:103-10. FI:4,426(Q1).
  • Torrecilla M, Fernández-Aedo I, Arrue A, Zumarraga M, Ugedo L. Role of GIRK channels on the noradrenergic transmission in vivo: an electrophysiological and neurochemical study on GIRK2 mutant mice. Int J Neuropsychopharmacol. 2013;16:1093-104. FI:5,264(Q1).